One Year Clinical Evaluation of IPS Empress CAD Versus Polished Celtra Duo Ceramic Laminate Veneers
Launched by CAIRO UNIVERSITY · Apr 27, 2017
Trial Information
Current as of April 26, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- All subjects are required to be:
- • 1. From 18-50 years old, be able to read and sign the informed consent document.
- • 2. Have no active periodontal or pulpal diseases, have teeth with good restorations
- • 3. Psychologically and physically able to tolerate conventional dental procedures
- 4. Patients with teeth problems indicated for laminate veneer:
- • 1. Discoloration
- • 2. Fracture not involving more than 50% enamel loss
- • 3. Mild malposition
- • 4. Diastema
- • 5. Enamel fluorosis
- • 6. Stained or defective restorations
- • 5. Able to return for follow-up examinations and evaluation
- Exclusion Criteria:
- • 1. Patient with post and core endodontically treated teeth
- • 2. Patient with fractured teeth of more than 50% enamel loss
- • 3. Patients with poor oral hygiene and motivation
- • 4. Pregnant women's
- • 5. Patients in the growth stage with partially erupted teeth
- • 6. Psychiatric problems or unrealistic expectations
- • 7. Lack of opposing dentition in the area of interest
- • 8. Patients involved in contact sports
- • 9. Teeth with deep discoloration
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials